$0.8900
-0.0896-9.15%
Last update: Nov 6, 5:28 PM
FibroBiologics Inc
FBLGNASDAQ
The average analyst price target for FibroBiologics is $188.67, 21098.9% above the current price. Of 5 analysts, 3 rate it Buy and 2 Hold. Targets range from $6 to $320. The latest change came on Aug 4, 2026, when HC Wainwright & Co. lowered its price target on FibroBiologics from $8 to $6 and kept a Buy rating.
Price Target Range — 9 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
